Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Current Assets (2019 - 2025)

Historic Current Assets for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $1.0 billion.

  • CureVac's Current Assets rose 5895.38% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 5895.38%. This contributed to the annual value of $562.5 million for FY2024, which is 928.96% up from last year.
  • CureVac's Current Assets amounted to $1.0 billion in Q3 2025, which was up 5895.38% from $475.2 million recorded in Q2 2025.
  • CureVac's Current Assets' 5-year high stood at $1.9 billion during Q2 2021, with a 5-year trough of $270.9 million in Q2 2024.
  • Over the past 5 years, CureVac's median Current Assets value was $634.8 million (recorded in 2022), while the average stood at $773.7 million.
  • In the last 5 years, CureVac's Current Assets skyrocketed by 16025487.99% in 2021 and then tumbled by 6341.07% in 2022.
  • Quarter analysis of 5 years shows CureVac's Current Assets stood at $1.1 billion in 2021, then crashed by 44.59% to $595.9 million in 2022, then dropped by 13.62% to $514.7 million in 2023, then rose by 9.29% to $562.5 million in 2024, then skyrocketed by 81.45% to $1.0 billion in 2025.
  • Its Current Assets stands at $1.0 billion for Q3 2025, versus $475.2 million for Q2 2025 and $493.4 million for Q1 2025.